The cash they had they had already committed or spent. After the placement they will (only) have $120 mill
"Post transaction pro forma cash balance of approximately $120 million will support the
rapid growth of DroneShield’s R&D programs and fund potential strategic technology
acquisitions.
Assumes placement of $120m, excluding offer costs. Pro Forma cash balance adjusted
for committed inventory spend $45m, expected near-term inventory spend $50m, funding for current R&D programs, additional
inventory requirements and working capital.
- Forums
- ASX - By Stock
- Ann: Successful Completion of $120m Underwritten Placement
The cash they had they had already committed or spent. After the...
-
- There are more pages in this discussion • 226 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DRO (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.24 |
Change
-0.010(0.80%) |
Mkt cap ! $1.090B |
Open | High | Low | Value | Volume |
$1.25 | $1.25 | $1.24 | $488.0K | 391.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 88572 | $1.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.25 | 55901 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 147150 | 1.255 |
11 | 222396 | 1.250 |
10 | 228168 | 1.245 |
8 | 94270 | 1.240 |
12 | 100951 | 1.235 |
Price($) | Vol. | No. |
---|---|---|
1.265 | 165685 | 6 |
1.270 | 105173 | 10 |
1.275 | 196142 | 11 |
1.280 | 88212 | 7 |
1.285 | 16545 | 2 |
Last trade - 10.02am 11/10/2024 (20 minute delay) ? |
Featured News
DRO (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online